Zoekresultaten - 4 results
COVID-19 vaccine effectiveness against symptomatic infection and hospitalisation in Belgium, July 2021 to May 2022.
used a test-negative design and proportional hazard regression to estimate VE i and VE h, controlling for prior infection, time since vaccination, age, sex, residence and calendar week of ...
Investigating COVID-19 Vaccine Impact on the Risk of Hospitalisation through the Analysis of National Surveillance Data Collected in Belgium.
Weyenbergh; Lucy Catteau; Simon Dellicour Source: Viruses, Volume 14, Issue 6 (2022) Keywords: Aged Belgium COVID-19 COVID-19 Vaccines Hospitalization Humans SARS-CoV-2 Vaccination Abstract: The national ...
Vaccine effectiveness against onward transmission of SARS-CoV2-infection by variant of concern and time since vaccination, Belgian contact tracing, 2021.
Pierre Hubin; Matthieu Billuart; Achille Djiena; Romain Mahieu; Hammami, Naïma; Dieter Van Cauteren; Chloé Wyndham-Thomas Source: Vaccine, Volume 40, Issue 22 (2022) Keywords: Ad26COVS1 Aged Aged, 80 and ...
Poor antibody response to BioNTech/Pfizer COVID-19 vaccination in SARS-CoV-2 naïve residents of nursing homes.
death and may respond poorly to vaccination because of old age and frequent comorbidities. METHODS: Seventy-eight residents and 106 staff members, naïve or previously infected with SARS-CoV-2, were ...